Human Histology and Persistence of Various Injectable Filler Substances for Soft Tissue Augmentation
DOI 10.1007/s00266-003-3022-1
Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg. 2003;27(5):354-366 (Pubitemid 38365030)
In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin
DOI 10.1001/archderm.143.2.155
Wang F, Garza LA, Kang S, Varani J, Orringer JS, Fisher GJ, Voorhees JJ. In vivo stimulation of de nove collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol. 2007;143(2):155-163. (Pubitemid 46294581)
A controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite (Radiesse®) premixed with lidocaine for correction of nasolabial folds
In press
Marmur E, Green L, Busso M. A controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite (Radiesse®) premixed with lidocaine for correction of nasolabial folds. Dermatol Surg. 2009 [In press].
An investigation of changes in physical properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine/epinephrine
Busso M and Voigts R. An investigation of changes in physical properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine/epinephrine. Dermatol Surg 2008;34 Suppl 1:S16-S23.
Six-month safety results of calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds in Fitzpatrick Skin Types of IV-VI
In press
Marmur ES, Taylor SC, Grimes PE, et al. Six-month safety results of calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds in Fitzpatrick Skin Types of IV-VI. Dermatol Surg. 2009 [In press].